Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stoeckel

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1990
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosisW L Hayton, J Kneer, R A Blouin, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Effect of probenecid on the elimination and protein binding of ceftriaxoneK Stoeckel, V Trueb, U C Dubach, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1984
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humansE Weidekamm, K Stoeckel, H J Egger, et al.
Journal of Clinical Pharmacology|December 1, 1996
Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltrationU F Kroh, H Lennartz, D J Edwards, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteersY K Tam, J Kneer, U C Dubach, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
Bioavailability of syrup and tablet formulations of cefetamet pivoxilM P Ducharme, D J Edwards, P J McNamara, et al.
Chemotherapy|April 29, 1998
Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in childrenH Scholz, T Hofmann, R Noack, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humansJ R Koup, U C Dubach, R Brandt, et al.
Reviews of Infectious Diseases|March 1, 1982
New analogs of trimethoprimR L Then, E Böhni, P Angehrn, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Screening methods using sulfamethazine for determining acetylator phenotypeP du Souich, A J McLean, K Stoeckel, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|July 1, 1990
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosisW L Hayton, J Kneer, R A Blouin, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Effect of probenecid on the elimination and protein binding of ceftriaxoneK Stoeckel, V Trueb, U C Dubach, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1984
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humansE Weidekamm, K Stoeckel, H J Egger, et al.
Journal of Clinical Pharmacology|December 1, 1996
Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltrationU F Kroh, H Lennartz, D J Edwards, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteersY K Tam, J Kneer, U C Dubach, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
Bioavailability of syrup and tablet formulations of cefetamet pivoxilM P Ducharme, D J Edwards, P J McNamara, et al.
Chemotherapy|April 29, 1998
Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in childrenH Scholz, T Hofmann, R Noack, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1988
Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humansJ R Koup, U C Dubach, R Brandt, et al.
Reviews of Infectious Diseases|March 1, 1982
New analogs of trimethoprimR L Then, E Böhni, P Angehrn, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Screening methods using sulfamethazine for determining acetylator phenotypeP du Souich, A J McLean, K Stoeckel, et al.
Pageof 7